|
Product
|
FGF-basic (146aa), Human
|
|
Cat#
|
101-19-83C
|
|
Sequence
|
PALPEDGGSG AFPPGHFKDP KRLYCKNGGF FLRIHPDGRV
DGVREKSDPH IKLQLQAEER GVVSIKGVCA NRYLAMKEDG
RLLASKCVTD ECFFFERLES NNYNTYRSRK YTSWYVALKR
TGQYKLGSKT GPGQKAILFL PMSAKS
|
|
Unit/Weight
|
1 mg
|
|
Unit Price
|
$593.00
|
|
Description
|
Fibroblast Growth Factor-basic (FGF-basic), also known as FGF-2, is a pleiotropic cytokine and one of the prototypic members of the heparin-binding FGF family. Like other FGF family members, FGF-basic has the β trefoil structure. In vivo, FGF-basic is produced by a variety of cells, including cardiomycotes, fibroblasts, and vascular cells. FGF-basic regulates a variety of processes including cell proliferation, differentiation, survival, adhesion, motility, apoptosis, limb formation and wound healing. FGF-basic can be tumorigenic due to its role in angiogenesis and blood vessel remodeling. The angiogenic effects of FGF-basic can produce beneficial cardioprotection during acute heart injury.
Recombinant human Fibroblast Growth Factor-basic (146 a.a.) (rhFGF-basic) produced in E. coli is a single non-glycosylated polypeptide chain containing 146 amino acids. A fully biologically active molecule, rhFGF-basic has a molecular mass of 16.4 kDa analyzed by reducing SDS-PAGE and is obtained by proprietary chromatographic techniques at Pepmic.
|
|
Molecular Weight
|
16.4 kDa, observed by reducing SDS-PAGE.
|
|
Purity
|
> 95% by SDS-PAGE analysis.
|
|
Storage
|
Lyophilized recombinant human Fibroblast Growth Factor-basic (146 a.a.) (rhFGF-basic) remains stable up to 6 months at -80°C from date of receipt. Upon reconstitution, rhFGF-basic remains stable up to 2 weeks at 4°C or up to 3 months at -20°C.
|
|